Stock Events

Stock Events

Genus 

$35.97
20
+$0.97+2.76% Monday 20:00

Statistics

Day High
35
Day Low
35
52W High
37.25
52W Low
21
Volume
145
Avg. Volume
9
Mkt Cap
0
P/E Ratio
92.5
Dividend Yield
1.21%
Dividend
0.44

Upcoming

9
NOV
Dividend Ex
Estimated
 
4
DEC
Dividend Payment
Estimated
 
8
MAR 27
Dividend Ex
Estimated
 
26
MAR 27
Dividend Payment
Estimated
 
8
NOV 27
Dividend Ex
Estimated
 

Dividends

1.21%Dividend Yield
Mar 26
$0.15
Dec 25
$0.29
Apr 25
$0.13
Dec 24
$0.28
Mar 24
$0.13
10Y Growth
4.25%
5Y Growth
0%
3Y Growth
3.95%
1Y Growth
4.09%

Earnings

26FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
19.98
39.95
59.93
Expected EPS
N/A
Actual EPS
59.92803648

Financials

2.92%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.81BRevenue
52.81MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GENSF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap51.98B
Zoetis is a global animal health company that offers products and services for livestock, which competes directly with Genus's offerings in animal genetics and health.
Elanco Animal Health
ELAN
Mkt Cap11.47B
Elanco Animal Health provides a range of products for animal health and welfare, competing in the same market as Genus, particularly in the livestock sector.
Idexx Laboratories
IDXX
Mkt Cap45.35B
IDEXX Laboratories specializes in diagnostics and healthcare for animals, competing with Genus in the broader animal health market.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories, through its animal health division, competes with Genus in providing products for livestock health and productivity.
Phibro Animal Health
PAHC
Mkt Cap1.76B
Phibro Animal Health Corporation offers animal health and nutritional products for livestock, directly competing with Genus in the animal health sector.
Vir Biotechnology
VIR
Mkt Cap1.45B
Virbac provides veterinary products and services, competing with Genus in the global animal health market, especially in the care and productivity of livestock.
BWX Technologies
BWXT
Mkt Cap19.69B
BWX Technologies, though primarily focused on nuclear technology, has divisions that could overlap with biotechnological advancements in animal genetics, representing a potential indirect competitor to Genus in innovative animal health solutions.

About

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Show more...
CEO
Mr. Jorgen Kokke
Employees
3500
Country
GB
ISIN
GB0002074580

Listings

OTC Link
US
GENSY
F
DE
GBE.F
OTC Link
US
GENSF
LSE
GB
GNS.LSE

0 Comments

Share your thoughts

FAQ

What is Genus stock price today?▼
The current price of GENSF is $35.97 USD — it has increased by +2.76% in the past 24 hours. Watch Genus stock price performance more closely on the chart.
What is Genus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genus stocks are traded under the ticker GENSF.
Is Genus stock price growing?▼
GENSF stock has risen by +0% compared to the previous week, the month change is a +2.76% rise, over the last year Genus has showed a +43.29% increase.
When is the next Genus earnings date?▼
Genus is going to release the next earnings report on September 10, 2026.
What were Genus earnings last quarter?▼
GENSF earnings for the last quarter are 0.81 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genus revenue for the last year?▼
Genus revenue for the last year amounts to 1.81B USD.
What is Genus net income for the last year?▼
GENSF net income for the last year is 52.81M USD.
Does Genus pay dividends?▼
Yes, GENSF dividends are paid semi-annual. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 1.21%.
How many employees does Genus have?▼
As of April 06, 2026, the company has 3,500 employees.
In which sector is Genus located?▼
Genus operates in the Health Care sector.
When did Genus complete a stock split?▼
Genus has not had any recent stock splits.
Where is Genus headquartered?▼
Genus is headquartered in Basingstoke, GB.